ImmunityBio (IBRX) FCF Margin Growth (5y) (2019 - 2026)
ImmunityBio (IBRX) FCF Margin Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | ImmunityBio | 7.60 Bn | 7.22 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.64 Mn |
| Dec 31, 2025 | 26.61 Mn |
| Sep 30, 2025 | 2.43 Mn |
| Jun 30, 2025 | 1.07 Mn |
| Mar 31, 2025 | 1.86 Mn |
| Dec 31, 2024 | 117.82 Mn |
| Sep 30, 2024 | 15.47 Mn |
| Jun 30, 2024 | 9.70 Mn |
| Mar 31, 2024 | -920,750.00 |
| Dec 31, 2023 | 15.59 Mn |
| Sep 30, 2023 | -3.07 Mn |
| Jun 30, 2023 | 27.95 Mn |
| Mar 31, 2023 | 37.96 Mn |
| Dec 31, 2022 | -3.65 Mn |
| Sep 30, 2022 | 4.47 Mn |
| Jun 30, 2022 | -31.34 Mn |
| Mar 31, 2022 | -40.21 Mn |
| Dec 31, 2021 | 5.81 Mn |
| Sep 30, 2021 | -2.41 Mn |
| Jun 30, 2021 | 4.11 Mn |